RecruitingNCT04306432
Cognitive Function After Radiation Therapy for Primary Brain Tumours
Sponsor
University of Aarhus
Enrollment
300 participants
Start Date
Jan 3, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria4
- years or older and Danish speaking.
- Performance status WHO 0-2
- Capable of cooperating on testing
- Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas
Exclusion Criteria2
- Glioblastoma
- Performance status 3-4 (Karnofsky Performances of 60 or less)
Interventions
OTHERCognitive tests and Patient Reported Outcomes
Each patient will undergo cognitive tests and questionnaires
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04306432
Related Trials
Mind Your Heart-II
NCT054311921 location
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT0407530518 locations
Curatively Intended Thoracic Reirradiation
NCT069500731 location
Visual Frailty in Ageing
NCT066041042 locations
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
NCT0708483116 locations